MARKET WIRE NEWS

Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-13 13:51:34 ET

Innate Pharma S.A. (IPHA)

Q1 2025 Earnings Conference Call

May 13, 2025 8:00 am ET

Corporate Participants

Henry Wheeler - VP, IR and Communications

Jonathan Dickinson - Chief Executive Officer

Yannis Morel - Chief Operating Officer

Sonia Quaratino - Chief Medical Officer

Frederic Lombard - Chief Financial Officer

Conference Call Participants

Daina Graybosch - Leerink Partners

Swayampakula Ramakanth - H.C. Wainwright

Rajan Sharma - Goldman Sachs

Presentation

Operator

Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today. At this time, I would like to welcome everyone to the Innate Pharma First Quarter 2025 Financial Results and Business Update Conference Call.

[Operator Instructions]. Thank you.

I would now like to turn the call over to Henry Wheeler, Vice President of Investor Relations. You may go ahead....

Read the full article on Seeking Alpha

For further details see:

Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript
Innate Pharma S.A.

NASDAQ: IPHA

IPHA Trading

-0.63% G/L:

$1.59 Last:

13,204 Volume:

$1.60 Open:

mwn-alerts Ad 300

IPHA Latest News

IPHA Stock Data

$162,196,580
59,035,869
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
FR
Marseille

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App